Memorial Göztepe Hospital
No hidden fees – just official clinic prices. Pay at the clinic for Friedreich’s Ataxia treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Friedreich’s Ataxia treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Friedreich’s Ataxia treatment journey.
Dr. Ibrahim Ziyal is a neurosurgeon at Memorial Göztepe Hospital in Istanbul (2025–present). He was Professor and Head of Neurosurgery at Marmara University (2012–2025). Earlier, he held faculty roles at Hacettepe University (2001–2012). He was the Founding Head of Neurosurgery at Abant İzzet Baysal University, Düzce (1999–2001). He also worked as a clinical researcher in brain tumors at George Washington University (1996–1998). He then focused on cerebrovascular diseases at the São Paulo Institute of Neurological Sciences (1998–1999).
Expertise: skull base tumors, pituitary surgery, and aneurysm/AVM/cavernoma surgery. Neurosurgery training: Şişli Etfal Hospital. MD: Trakya University. Memberships: Turkish Neurosurgical Society, Neuro-Oncology Association, AANS, CNS, WFNS, EANS.
Turkish centers manage Friedreich’s Ataxia through multidisciplinary neurological care and specialized symptom management. Treatment protocols integrate advanced imaging like AI-supported 3 Tesla MRI with cardiac monitoring and orthopedic support. Clinics prioritize physical rehabilitation and endocrine monitoring to address mobility issues and diabetes risk.
Bookimed Expert Insight: Turkish hospitals like Memorial Göztepe focus on integrated research units. These units facilitate access to global innovations before they reach standard care. Patients should look for facilities with dedicated clinical research departments for potential trial participation. This allows access to emerging mitochondrial boosters or gene therapy protocols.
Turkey actively recruits for clinical trials through academic centers and specialized research units. Locations like Istanbul and Antalya often serve as sites for global neurology studies. Patients can access innovative treatments for Friedreich's Ataxia through centers such as Memorial Goztepe Hospital.
Bookimed Expert Insight: Clinical research activity is concentrated in private university hospitals with dedicated research units. Memorial Goztepe Hospital, founded in 2025, features a specialized clinical research unit. This facility offers patients direct access to global pharmaceutical innovations that are not yet available commercially.
Patient Consensus: Patients emphasize verifying if a global trial is enrolling at specific Turkish sites. Many travelers found that eligibility criteria like mobility status and age are strictly enforced early on.
SKYCLARYS (omaveloxolone) lacks routine accessibility in Turkey as of late 2024. The Turkish Medicines and Medical Devices Agency (TITCK) has not granted standard marketing authorization. Patients typically access this orphan drug through Named Patient Programs or specialized import pathways at major neurological centers.
Bookimed Expert Insight: While standard pharmacies do not stock the drug, academic centers in Istanbul often facilitate access. Memorial Goeztepe Hospital features a dedicated clinical research unit. This infrastructure suggests that large, multidisciplinary facilities are better equipped to navigate the complex import paperwork for orphan drugs compared to smaller private clinics.
Patient Consensus: Patients note that obtaining this drug requires working with a rare-disease specialist to manage individual import requests. Many emphasize that local availability is often delayed even after FDA approval in the United States.
Leading Turkish hospitals manage Friedreich's Ataxia through multidisciplinary neurology, cardiology, and orthopedic care. Memorial Goztepe Hospital and Medipol University Pendik Hospital provide advanced infrastructure. These centers use AI-supported 3 Tesla MRI and robotic gait training to address balance and coordination issues effectively.
Bookimed Expert Insight: Memorial Health Group centers facilitate high-volume care with 19 operating rooms. Memorial Goztepe Hospital alone spans 81,000 square meters. Its clinical research unit offers patients potential access to emerging global treatment innovations. This infrastructure supports the complex, long-term monitoring required for progressive neurogenetic conditions.
Optimal care for Friedreichs Ataxia requires a specialized neurologist. You should seek an ataxia specialist, neurogeneticist, or neuromuscular specialist. These experts manage the complex genetic progression. They also coordinate vital care for heart and skeletal issues. General neurologists may only treat basic symptoms.
Bookimed Expert Insight: Turkish academic centers like Memorial Göztepe Hospital utilize multidisciplinary boards for complex cases. Our data shows specialized centers often house over 90 doctors. This allows neurologists to collaborate instantly with cardiology teams. Patients should prioritize these large facilities in Istanbul for comprehensive FA evaluation.
Patient Consensus: Patients emphasize that while general neurologists manage routine symptoms, specialists recognize rare patterns faster. Many recommend bringing genetic test results to the first visit to assist the coordination of care.
Turkish neurology centers provide multidisciplinary follow-up for Friedreich's Ataxia after initial treatment begins. Management typically includes ongoing neurological monitoring, cardiac evaluations, and intensive physical rehabilitation. Facilities like Memorial Göztepe Hospital utilize advanced imaging like 3 Tesla MRI for precise disease tracking.
Bookimed Expert Insight: Turkish hospitals often function as acute treatment hubs rather than long-term residential care. While 390 clinics serve international patients, local management usually focuses on intensive 14-day cycles. Patients should secure a written monitoring plan to share with home-country doctors. This ensures medication adjustments and cardiac screenings remain consistent after discharge.
Patient Consensus: Patients emphasize that comprehensive care must include clear communication after returning home. They often suggest confirming exactly how doctors manage complications once travel concludes.